NM_005257.6:c.826G>A
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_005257.6(GATA6):c.826G>A(p.Ala276Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005257.6 missense
Scores
Clinical Significance
Conservation
Publications
- atrial septal defect 9Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Ambry Genetics
- atrioventricular septal defect 5Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pancreatic hypoplasia-diabetes-congenital heart disease syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- metabolic syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- neonatal diabetes mellitusInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tetralogy of fallotInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- conotruncal heart malformationsInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GATA6 | ENST00000269216.10 | c.826G>A | p.Ala276Thr | missense_variant | Exon 2 of 7 | 1 | NM_005257.6 | ENSP00000269216.3 | ||
| GATA6 | ENST00000581694.1 | c.826G>A | p.Ala276Thr | missense_variant | Exon 1 of 6 | 1 | ENSP00000462313.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1058822Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 499620
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Atrioventricular septal defect 5 Uncertain:1
In summary, this variant is a novel missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a GATA6-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. This sequence change replaces alanine with threonine at codon 276 of the GATA6 protein (p.Ala276Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at